Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 2 11Phase 3 8Phase 1 7Phase 1/2 6Phase 2/3 2

Status

Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 6NIH 1

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Squamous Cell Carcinoma of Head and Neck 14Head and Neck Neoplasms 11Glioblastoma 8Prostatic Neoplasms 7Carcinoma 6Rectal Neoplasms 5Pancreatic Neoplasms 5Gliosarcoma 5Carcinoma, Non-Small-Cell Lung 5Astrocytoma 5Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Neoplasms 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Medulloblastoma 2Lymphoma, Follicular 2Lymphoma 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT03269422 2025-09-30

Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL)

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
35 enrolled
Genitourinary

Prostatic Neoplasms

NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Thomas Jefferson University

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT03066154 2024-06-03

DOP

The Netherlands Cancer Institute

Phase 1 Terminated
24 enrolled
Genitourinary

Prostatic Neoplasms

NCT00482807 2023-11-24

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

University of Nebraska

Phase 1 Completed
9 enrolled
Genitourinary

Prostatic Neoplasms

NCT02064036 2022-10-18

CCRO025

University of California, Davis

Phase 1 Completed
17 enrolled
Genitourinary

Prostatic Neoplasms

NCT01028885 2019-07-25

MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate

Abramson Cancer Center at Penn Medicine

Phase 1 Completed
10 enrolled
Genitourinary

Prostatic Neoplasms

NCT00946543 2013-08-26

Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
198 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡